ZA200702938B - Peptides and APL-type derivatives of Hsp60 and pharmaceutical compositions - Google Patents

Peptides and APL-type derivatives of Hsp60 and pharmaceutical compositions

Info

Publication number
ZA200702938B
ZA200702938B ZA200702938A ZA200702938A ZA200702938B ZA 200702938 B ZA200702938 B ZA 200702938B ZA 200702938 A ZA200702938 A ZA 200702938A ZA 200702938 A ZA200702938 A ZA 200702938A ZA 200702938 B ZA200702938 B ZA 200702938B
Authority
ZA
South Africa
Prior art keywords
hsp60
apl
peptides
pharmaceutical compositions
type derivatives
Prior art date
Application number
ZA200702938A
Other languages
English (en)
Inventor
Horta Maria Del Carmen Dominguez
Lopez Marin Nelia
Barbera Betancourt Ariana
Morera Cordova Vivian
Garcia Nelson J Merino
Sueez Alba Jose
Padro Palomares Gabriel Ramo
Lorenzo Perez Norailys
Hernadez Garcia Ariadna
Cosme Diaz Carelia
Vazquez Bonachea Ariel
Original Assignee
Ct De Ingeniera Genetica Y Bio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct De Ingeniera Genetica Y Bio filed Critical Ct De Ingeniera Genetica Y Bio
Publication of ZA200702938B publication Critical patent/ZA200702938B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ZA200702938A 2004-09-24 2007-04-10 Peptides and APL-type derivatives of Hsp60 and pharmaceutical compositions ZA200702938B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20040207A CU23504A1 (es) 2004-09-24 2004-09-24 Péptidos y derivados tipo apl de la hsp60 y composiciones farmacéuticas

Publications (1)

Publication Number Publication Date
ZA200702938B true ZA200702938B (en) 2008-08-27

Family

ID=40273413

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200702938A ZA200702938B (en) 2004-09-24 2007-04-10 Peptides and APL-type derivatives of Hsp60 and pharmaceutical compositions

Country Status (17)

Country Link
US (2) US8383771B2 (es)
EP (2) EP1803732B1 (es)
JP (1) JP4755649B2 (es)
KR (2) KR101035283B1 (es)
CN (2) CN101935345B (es)
AR (2) AR051928A1 (es)
AT (1) ATE546462T1 (es)
AU (2) AU2005287757B2 (es)
BR (2) BR122018077204B8 (es)
CA (2) CA2797769C (es)
CU (1) CU23504A1 (es)
DK (2) DK1803732T3 (es)
ES (2) ES2445707T3 (es)
MX (1) MX2007003624A (es)
RU (1) RU2361877C2 (es)
WO (1) WO2006032216A2 (es)
ZA (1) ZA200702938B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2423220B1 (en) * 2007-01-30 2015-04-29 Epivax, Inc. Regulatory t cell epitopes, compositions and uses thereof
CU23701A1 (es) * 2008-12-29 2011-09-21 Ct Ingenieria Genetica Biotech Método de tratamiento de enfermedades inflamatorias intestinales y diabetes tipo i
US8680241B2 (en) * 2009-09-06 2014-03-25 Protab Ltd. Humanized antibodies specific for HSP65-derived peptide-6 methods and uses thereof
WO2011059758A2 (en) * 2009-10-28 2011-05-19 Argentis Pharmaceuticals, Llc Apls for treating arthritis
CU24508B1 (es) * 2017-12-29 2021-04-07 Centro De Ingenieria Genetica Y Biotecnologia Biocubafarma Composición farmacéutica que comprende péptido tipo apl
CU20200026A7 (es) * 2020-04-13 2021-11-04 Ct Ingenieria Genetica Biotecnologia Péptido para el tratamiento del síndrome de la tormenta de citocinas
CN111870697B (zh) * 2020-09-18 2022-09-09 山东鲁抗医药股份有限公司 糖类物质在提高apl型衍生肽稳定性中的应用和冻干组合物
KR102333645B1 (ko) 2021-07-27 2021-12-02 (주)문화전기 각도조절이 용이한 엘이디조명시스템
CN115671253B (zh) * 2021-07-30 2024-02-27 河北菲尼斯生物技术有限公司 Se-dr亲和肽在制备治疗风湿疾病的药物中的用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8701163A (nl) 1986-09-09 1988-04-05 Nederlanden Staat Gebruik van een peptide voor de bereiding van preparaten voor het verlichten, het behandelen en de diagnose van autoimmuunziekten, in het bijzonder arthritische toestanden, verbindingen die met dit peptide verwant zijn, alsmede farmaceutische en diagnostische preparaten en testkits.
NL8703107A (nl) 1987-12-22 1989-07-17 Nederlanden Staat Polypeptiden en derivaten daarvan, alsmede de toepassing daarvan in farmaceutische en diagnostische preparaten.
US5773570A (en) 1994-05-20 1998-06-30 The Regents Of The University Of California Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis
GB9419553D0 (en) 1994-09-27 1994-11-16 Univ Bristol Polypeptides and their use in the treatment of auto-immune disease
US6180103B1 (en) 1994-12-21 2001-01-30 Yeda Research And Development Co., Ltd. Peptide p277 analogs, and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes
GB9519737D0 (en) * 1995-09-27 1995-11-29 Peptide Therapeutics Ltd Polypeptides and their use in treatment and prophylaxis of auto-immune
US5993803A (en) 1996-08-30 1999-11-30 Yeda Research And Development Co., Ltd. Method of reducing the severity of host vs graft reaction by down-regulating hsp60 autoimmunity
GB9911772D0 (en) 1999-05-21 1999-07-21 Semmelweis University Of Medic Diagnosis and treatment of atherosclerosis
US20020169302A1 (en) * 1999-08-23 2002-11-14 Genesis Research And Development Corp. Ltd. Compositions isolated from bovine mammary gland and methods for their use
CA2394504A1 (en) * 1999-12-15 2001-06-21 Peptor Ltd. Fragments and antagonists of heat shock protein 60
JP2005503533A (ja) 2001-01-19 2005-02-03 ケンブリッジ サイエンティフィック， インコーポレイテッド 骨粗鬆症の診断方法および処置方法

Also Published As

Publication number Publication date
ES2445707T3 (es) 2014-03-04
DK1803732T3 (da) 2012-05-29
CA2581110A1 (en) 2006-03-30
KR20100028645A (ko) 2010-03-12
AU2010219312A1 (en) 2010-09-23
EP2371847A1 (en) 2011-10-05
CA2797769A1 (en) 2006-03-30
CN101935345A (zh) 2011-01-05
EP1803732A2 (en) 2007-07-04
US20090171069A1 (en) 2009-07-02
AU2010219312B2 (en) 2011-10-06
US8383771B2 (en) 2013-02-26
DK2371847T3 (da) 2014-02-03
ATE546462T1 (de) 2012-03-15
KR101035283B1 (ko) 2011-05-18
WO2006032216A2 (es) 2006-03-30
US20100144642A1 (en) 2010-06-10
AR074924A2 (es) 2011-02-23
EP1803732B1 (en) 2012-02-22
BR122018077204B1 (pt) 2020-01-28
JP4755649B2 (ja) 2011-08-24
EP2371847B1 (en) 2013-11-20
CA2797769C (en) 2015-09-15
KR101054332B1 (ko) 2011-08-04
US8324164B2 (en) 2012-12-04
CU23504A1 (es) 2010-04-13
BRPI0515893B1 (pt) 2020-09-15
WO2006032216A3 (es) 2007-05-18
CN101065398A (zh) 2007-10-31
ES2386498T3 (es) 2012-08-22
BR122018077204B8 (pt) 2021-07-27
AU2005287757A1 (en) 2006-03-30
BRPI0515893B8 (pt) 2021-05-25
BRPI0515893A8 (pt) 2019-01-02
BRPI0515893A (pt) 2008-08-12
KR20070073787A (ko) 2007-07-10
MX2007003624A (es) 2007-06-13
CA2581110C (en) 2013-04-02
AR051928A1 (es) 2007-02-21
CN101935345B (zh) 2013-12-11
JP2008514553A (ja) 2008-05-08
RU2007115411A (ru) 2008-10-27
AU2005287757B2 (en) 2010-07-29
RU2361877C2 (ru) 2009-07-20
CN101065398B (zh) 2012-12-19

Similar Documents

Publication Publication Date Title
HK1221252A1 (zh) 限制的 肽及含有其的藥物組合物
HK1119951A1 (en) Methods and compositions for oral administration of proteins
IL178070A (en) Antibiotic p-selectin antibodies and pharmaceuticals that include them
IL190292A (en) History of pyridopyrimidinone and their pharmaceutical preparations
EP1773369A4 (en) PHARMACEUTICAL COMPOSITIONS AND METHOD FOR THE PEPTIDE TREATMENT
ZA200702938B (en) Peptides and APL-type derivatives of Hsp60 and pharmaceutical compositions
EP1765379A4 (en) CO-CRISTAL PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF
IL186959A0 (en) Peptides and pharmaceutical compositions containing the same
IL194429A0 (en) Camptothecin-cell penetrating peptide conjugates and pharmaceutical compositions containing the same
IL177168A0 (en) N-sulphonylpyrrole derivatives and pharmaceutical compositions containing the same
IL184735A0 (en) Pharmaceutical formulations and methods of use
EP1890677A4 (en) PHARMACEUTICAL COMPOSITIONS AND THEIR USE
IL221323A0 (en) 1-methyl-1h- pyridin-2-one- phenanthridine derivatives and pharmaceutical compositions containing the same
PL1890720T3 (pl) Kompozycje farmaceutyczne zawierające peptydy pochodzące z kazeiny i sposoby ich stosowania
IL170313A (en) Diarylcycloalkyl derivatives and pharmaceutical compositions comprising them
IL178067A0 (en) Pharmaceutical dosage forms and compositions
IL183986A0 (en) Pharmaceutical compounds and compositions
IL221395A0 (en) Pharmaceutical compositions comprising alpha ketoamide derivatives and uses thereof
ZA200702038B (en) Pharmaceutical composition drospirenone and ethynyle-stradiol
IL181730A0 (en) Benzodiazinone derivatives and pharmaceutical compositions containing the same
IL177498A0 (en) Difluoroethoxy -substituted hydroxy-6-phenylphenanthridine derivatives and pharmaceutical compositions containing the same
GB0404327D0 (en) Pharmaceutical composition and method of using same
IL177497A0 (en) Isoamido-substituted hydroxy-6-phenylphenanthridine derivatives and pharmaceutical compositions containing the same
ZA200700178B (en) Pharmaceutical composition containing polypeptide fragments of serralysins
EP1937292A4 (en) LOPAP-BASED PHARMACEUTICAL COMPOSITIONS AND USES THEREOF